- Filed
- Apr 11, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Apr 10, 2025 | 53.2M sh |
| Cash And Equivalents | Q2 2025 · Feb 28, 2025 | $3.8M |
| Cash And Equivalents | Q2 2025 · Aug 31, 2024 | $1.25M |
| Current Liabilities | Q2 2025 · Feb 28, 2025 | $357.58K |
| Current Liabilities | Q2 2025 · Aug 31, 2024 | $321.51K |
| Total Liabilities | Q2 2025 · Feb 28, 2025 | $357.58K |
| Total Liabilities | Q2 2025 · Aug 31, 2024 | $321.51K |
| Current Assets | Q2 2025 · Feb 28, 2025 | $3.93M |
| Current Assets | Q2 2025 · Aug 31, 2024 | $4.99M |
| Total Assets | Q2 2025 · Feb 28, 2025 | $3.94M |
| Total Assets | Q2 2025 · Aug 31, 2024 | $5M |
| Short Term Investments | Q2 2025 · Aug 31, 2024 | $3M |
| Shares Diluted | Q2 2025 · Feb 29, 2024 | 53.2M sh |
| Shares Diluted | Q2 2025 · Feb 29, 2024 | 53.2M sh |
| Operating Cash Flow | Q2 2025 · Feb 29, 2024 | −$791.5K |
| Stockholders Equity | Q2 2025 · Feb 29, 2024 | $6.46M |
| Stockholders Equity | Q2 2025 · Nov 30, 2023 | $6.85M |
| Stockholders Equity | Q2 2025 · Aug 31, 2023 | $7.33M |
| Eps Diluted | Q2 2025 · Feb 29, 2024 | −$0.02 |
| Eps Diluted restated | Q2 2025 · Feb 29, 2024 | −$0.02 |
| Eps Basic | Q2 2025 · Feb 29, 2024 | −$0.02 |
| Eps Basic restated | Q2 2025 · Feb 29, 2024 | −$0.02 |
| Sga Expense | Q2 2025 · Feb 29, 2024 | $369.32K |
| Sga Expense | Q2 2025 · Feb 29, 2024 | $820.82K |
| Rd Expense | Q2 2025 · Feb 29, 2024 | $132.64K |
| Rd Expense | Q2 2025 · Feb 29, 2024 | $249.33K |
| Net Income | Q2 2025 · Feb 29, 2024 | −$847.03K |
| Net Income | Q2 2025 · Feb 29, 2024 | −$1.35M |
| Operating Income | Q2 2025 · Feb 29, 2024 | −$501.96K |
| Operating Income | Q2 2025 · Feb 29, 2024 | −$1.07M |